Eltrombopag and its beneficial role in management of ulcerative Colitis associated with ITP as an upfront therapy case report

Elabbass A Abdelmahmuod; Elrazi Ali; Mohanad A Ahmed; Mohamed A Yassin

doi:10.1002/ccr3.3783

Eltrombopag and its beneficial role in management of ulcerative Colitis associated with ITP as an upfront therapy case report

Clin Case Rep. 2021 Jan 21;9(3):1416-1419. doi: 10.1002/ccr3.3783. eCollection 2021 Mar.

Authors

Elabbass A Abdelmahmuod¹, Elrazi Ali¹, Mohanad A Ahmed¹, Mohamed A Yassin²

Affiliations

¹ Department of Internal Medicine Hamad Medical Corporation Doha Qatar.
² Department of Hematology and Medical Oncology National Center for Cancer Care and Research Doha Qatar.

Abstract

Eltrombopag can be used safely as upfront medication in the management of ulcerative colitis as well as ITP, and it showed a beneficial effect in both disorders.

Keywords: IBD; ITP; eltrombopag; inflammatory bowel diseases; ulcerative colitis.

Publication types

Case Reports